2011, Number 6
Rev Mex Urol 2011; 71 (6)
Cáncer testicular. Experiencia en el Centro Médico del Instituto de Seguridad Social del Estado de México y Municipios (ISSEMyM)
Costilla-Montero A, Guadarrama-Benítez B, Aragón-Castro M, Gutiérrez-Rosales R, Morales-Ordaz O, Cisneros-Chávez R, Pérez-Guadarrama O, López-Zepeda A, Carrillo-Ponce C, Morales-Padilla CA
Full text
Language: Spanish
References: 10
Page: 307-313
PDF size: 516.57 Kb.
ABSTRACT
Introduction: Testicular cancer makes up 1-1.5% of tumors in men and 5% of urological tumors. There are three to six new cases per 100,000 men per year in the United States and 5% of cases are bilateral. According to the Mexican Malignant Tumor Histopathological Register (2001), testicular cancer is the most curable solid tumor, and after prostate cancer is the most frequent urological tumor in men in general, and the most frequent urological tumor in working-age men. The present study analyzes the results of an initial series of testicular cancer patients treated at the Urology Department of the Centro Médico del Instituto de Seguridad Social del Estado de México y Municipios (ISSEMyM).Objective: To present the experience of the authors’ department in testicular cancer management.
Methods: Case records were reviewed of patients with histopathological diagnosis corroborating testicular cancer within the time frame of November 2004 to July 2010 at the authors’ department. The factors that were analyzed were age at the time of diagnosis, genetic load for testicular cancer, and risk factors such as cryptorchidism. Each patient was evaluated by means of complete physical examination and basic laboratory and radiological work-ups that included: serum beta human chorionic gonadotropin, alpha fetoprotein, and lactate dehydrogenase determination; testicular ultrasound, chest film for evaluating metastasis to the thorax, and abdominopelvic computed tomography scan with and without contrast medium principally to rule out retroperitoneal metastatic disease.
Results: A total of thirty-six case records were reviewed, only thirty of which were complete and had adequate postoperative follow-up. Mean age of patients was 34.5 years with a 17-54 year range. Two patients (6.6%) had positive genetic load for cancer. Sixteen patients (52.8%) had cancer in the right testis and fourteen patients (47.2%) presented with left testicular disease. All patients underwent radical orchiectomy. Patient follow-up was from two months to five years and eight months and up to the present there have been no documented deaths from the disease in these patients.
Conclusions: The Centro Médico del Instituto de Seguridad Social del Estado de México y Municipios has had excellent results in the management of patients presenting with testicular cancer as well as in the majority of genitourinary tract diseases, which has been reflected in the marked reduction in morbidity and mortality of these patients.
REFERENCES